Boosting levels of the Cdk8 gene in fruit flies with Parkinson’s-like symptoms improved their ability to move, possibly due in part…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Amprion is launching SAAmplify, a set of biomarker panels that can be used as a tool to help in…
Vanderbilt University Medical Center (VUMC) in Nashville will soon treat movement disorders such as tremor and Parkinson’s disease using…
Machine learning, a form of artificial intelligence (AI), was able to define three distinct subtypes of Parkinson’s disease based…
People with Parkinson’s disease and cognitive impairment experience more severe symptoms and require more care but appear to use…
The Digital Medicine Society or DiMe, working with The Michael J. Fox Foundation (MJFF) and the Critical Path Institute…
GUCY2C — a protein found mainly in the gut, but also in the brain — appears to be produced in…
Clumps of alpha-synuclein, the protein responsible for nerve cell death in Parkinson’s disease, initially form under medium salt conditions.
A new collaboration dubbed the Accelerating Medicines Partnership in Parkinson’s Disease and Related Disorders, or simply AMP PDRD, will…
U.S. Marine Corps and Navy personnel exposed to trichloroethylene (TCE) and other industrial chemicals in drinking water at Camp Lejeune…